A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Author
KARAAĞAÇ AKYOL, TÜLAY
Kayikcioglu, Meral
Tokgozoglu, Lale
YILMAZ, MEHMET
KAYNAR, LEYLAGÜL
Gokce, Cumali
Temizhan, Ahmet
ÖZCEBE, OSMAN İLHAMİ
Okutan, Harika
Sag, Saim
Gul, Ozen Oz
Salcioglu, Zafer
Yenercag, Mustafa
Altunkeser, Bulent B.
KUKU, İRFAN
Yasar, Hamiyet Yilmaz
Kurtoglu, Erdal
Kose, Melis Demir
Demircioglu, Sinan
PEKKOLAY, ZAFER
İLHAN, OSMAN
Durmus, Rana Berru
Aktan, Melih
Metadata
Show full item record
Abstract
Background and aims: Homozygous familial hypercholesterolemia (HoFH) is a genetic condition characterized by lethally high levels of low-density lipoprotein cholesterol (LDL-C) from birth, and requires rapid and aggressive intervention to prevent death due to coronary heart disease and/or atherosclerosis. Where available, lipoprotein apheresis (LA) is the mainstay of treatment to promote survival.
URI
http://hdl.handle.net/20.500.12627/83017
https://doi.org/10.1016/j.atherosclerosis.2018.01.034
Collections